Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Reaches New 12-Month High – Still a Buy?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) shares hit a new 52-week high on Thursday . The stock traded as high as $10.2750 and last traded at $10.04, with a volume of 5791 shares changing hands. The stock had previously closed at $9.94.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

The firm has a 50-day moving average of $8.95 and a 200-day moving average of $8.70. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.74 and a current ratio of 6.44. The firm has a market capitalization of $17.27 billion, a P/E ratio of 15.86, a PEG ratio of 2.08 and a beta of 0.19.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last posted its earnings results on Monday, October 27th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.02. The business had revenue of $740.85 million during the quarter, compared to analyst estimates of $742.35 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 11.90% and a net margin of 39.53%. As a group, analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.